Seres Therapeutics Inc (MCRB)

NASDAQ

Currency in USD

Disclaimer

1.0500

0.0000(0.00%)

Closed19/09

After Hours

1.0499-0.0001(-0.0095%)

01:57:11

Fair Value

Unlock Value

Day's Range

1.0200

1.1000

52 wk Range

0.5400

2.7800

MCRB Cash Flow Statement
Featured here, the Cash Flow Statement for Seres Therapeutics Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Advanced Cash Flow Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Cash from Operations

aa.aa

-76.52

-93.61

6.69

-228.82

-117.35

	Cash from Operations Growth
	Net Income
	Depreciation & Amortisation, Total
	Amortisation of Deferred Charges, Total
	Other Non-Cash Items, Total
	Change in Net Operating Assets

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-21.74%	-22.33%	+107.14%	-3,521.29%	+48.71%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-70.28	-89.13	-65.58	-250.16	-113.72
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	7.6	6.58	5.95	11.83	15.14
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.28	0.55	2.53	0.71	1.14
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	10.5	11.59	22.26	27.2	39.07
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-24.63	-23.2	41.53	-18.39	-58.98

Cash from Investing

aa.aa

-30.52

-158.89

64.09

82.43

10.58

	Cash from Investing Growth
	Capital Expenditure
	Sale of Property, Plant, and Equipment
	Cash Acquisitions
	Divestitures
	Other Investing Activities

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-127.17%	-420.65%	+140.33%	+28.62%	-87.16%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1	-0.59	-9.57	-9.82	-7.98
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-29.52	-158.3	73.65	92.25	18.56

Cash from Financing

aa.aa

86.23

303.42

1.18

129.6

71.71

	Cash from Financing Growth
	Total Debt Issued
	Short Term Debt Issued, Total
	Long-Term Debt Issued, Total
	Total Debt Repaid
	Short Term Debt Repaid, Total
	Long-Term Debt Repaid, Total
	Issuance of Common Stock
	Repurchase of Common Stock
	Issuance of Preferred Stock
	Repurchase of Preferred Stock
	Common & Preferred Stock Dividends Paid
	Special Dividend Paid
	Other Financing Activities
	Foreign Exchange Rate Adjustments
	Miscellaneous Cash Flow Adjustments

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+32,075.75%	+251.87%	-99.61%	+10,901.87%	-44.67%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	25	-	-	27.61	103.38
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	25	-	-	27.61	103.38
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-0.95	-1.91	-52.86
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-0.95	-1.91	-52.86
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	61.66	303.42	2.13	103.9	21.19
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.43	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-0	-0	0
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Net Change in Cash

aa.aa

-20.81

50.92

71.95

-16.79

-35.07

	Beginning Cash Balance
	Ending Cash Balance
	Levered Free Cash Flow
	Levered Free Cash Flow Growth
	Free Cash Flow Yield

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	85.93	65.13	108.05	179.82	163.03
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	65.13	116.05	180	163.03	127.97
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-28.11	-52.03	14.04	-124.23	-56.9
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+10.61%	-85.08%	+126.99%	-984.66%	+54.2%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-39.67%	-4.82%	-0.38%	-39.43%	-69.94%

* In Millions of USD (except for per share items)

South Africa Top 40

75,810.20

+965.25

+1.29%

S. Africa 40 Futures

76,781.00

+1,058

+1.40%

US 30

42,030.00

+4.8

+0.01%

US 500

5,708.60

-5.0

-0.09%

US Tech 100

19,805.70

-31.2

-0.16%

DAX Futures

19,124.50

-16.9

-0.09%

Dollar Index

100.41

+0.055

+0.05%

Market Movers

Name	Last	Chg. %	Vol.
FirstRand Ltd	8,330	-0.34%	38.06M
Standard Bank	24,417	+1.61%	10.90M
ABSA	17,424	+2.01%	9.17M
Anglo American	50,900	+3.71%	4.07M
Prosus	66,043	+4.18%	2.40M
Naspers	367,447	+4.24%	1.11M
Capitec	301,601	+0.70%	613.68K

Name	Last	Chg. %	Vol.
Europa Metals	60	+20.00%	6.40K
Bytes Technology	12,014.00	+9.53%	54.51K
Mtn Zakhele Futhi	990.00	+8.67%	7.83K
Trematon Capital Investments	269	+7.60%	1.50K
Famous Brands	5,869	+7.16%	216.97K
Southern Sun	745.00	+6.43%	1.69M
Montauk Renewables	8,850.00	+6.37%	67.98K

Name	Last	Chg. %	Vol.
Bowler Metcalf Ltd	1,231	-10.80%	24.95K
Trustco Group Holdings	40	-6.98%	50.31K
AECI Pref	1,400	-5.08%	10.00K
ID Systems	8,751.00	-4.93%	1.33K
Transaction Capital	240	-4.76%	8.01M
Gemfields	260	-4.76%	270.92K
Mantengu Mining	81.00	-4.71%	324.60K

Trending Stocks

Name	Last	Chg. %	Vol.
Suprgrp	2,466	-0.16%	1.29M
Sibanye Stillwater	1,862	+2.14%	27.89M
Sasol	12,721	+2.14%	4.32M
Thungela Resources	10,388.00	-0.47%	571.30K
Growthpoint Properties	1,405	+0.36%	31.49M

Popular Searches

Please try another search

Seres Therapeutics Inc (MCRB)

MCRB Cash Flow Statement
Featured here, the Cash Flow Statement for Seres Therapeutics Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Trending Stocks

Please try another search

Seres Therapeutics Inc (MCRB)

MCRB Cash Flow StatementFeatured here, the Cash Flow Statement for Seres Therapeutics Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Trending Stocks

MCRB Cash Flow Statement
Featured here, the Cash Flow Statement for Seres Therapeutics Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).